Getting to the heart of the matter: CCN2 plays a role in cardiomyocyte hypertrophy by Leask, Andrew
BITS AND BYTES
Getting to the heart of the matter: CCN2 plays a role
in cardiomyocyte hypertrophy
Andrew Leask
Received: 1 August 2009 /Accepted: 12 August 2009 /Published online: 24 August 2009
# The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract Connective tissue growth factor (CTGF/CCN2)
is overexpressed in diabetes. Diabetic rats possess
myocardial and cardiomyocyte hypertrophy. In a recent
report, Wang and colleagues (Am J Physiol Cell Physiol.
2009 Jul 22. [Epub ahead of print]) show that CCN2
directly mediates cardiomyocyte hypertrophy as well as
that induced by high glucose and fatty acid. CCN2 acted
via the TrkA receptor. These data are the subject of this
commentary, and emphasize that CCN2 may be an
excellent target for therapy in diabetes.
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Diabetes not only characterized by kidney failure but
also can cause acute and chronic heart failure (diabetic
cardiomyopathy) characterized by cardiac hypertrophy,
apoptosis and excess accumulation of extracellular matrix
(Karnik et al. 2007; Feuvray and Darmellah 2008). The
proadhesive matricellular protein CCN2 is overexpressed
in diabetes and can promote hypertrophy, apoptosis and
fibrosis (Leask and Abraham 2006). Although CCN2 has
been proposed as a target for drug therapy in diabetes
(Mason 2009), whether CCN2 contributes to diabetic
cardiomyopathy is unknown.
A recent report by Wang et al. (2009)s h o w e dt h a t
recombinant CCN2 could directly promote both apoptosis
and hypertrophy in a cardiac myocyte cell line. Glucose
and the fatty acid palmitate induced both apoptosis and
hypertrophy in the same cell line. Glucose and the fatty
acid palmitate induced CCN2 mRNA and protein, and
siRNA against CCN2 significantly reduced the apoptosis
and hypertrophy caused by these agents. Previously, it
had been shown that CCN2 can bind and activate
the TrkA receptor in human kidney mesangial cells
(Wahab et al. 2005). Wang and colleagues (2009) found
that pharmacological inhibition of TrkA blocked aspects
of CCN2 activity.
That fatty acids can induce CCN2 lengthens the list of
agents, which were initially believed to include only TGFβ,
to promote CCN2 mRNA and protein expression (Blom et
al. 2002). These data are significant as these strongly
suggest that anti-CCN2 strategies may be useful in
targeting several aspects of diabetes in addition to diabetic
nephropathy and retinopathy (Mason 2009), and also
suggest that CCN2 may contribute to additional pathologies
induced by fatty acids including fatty liver disease (Paradis
et al. 2001). Future efforts, no doubt, will be focused on
expanding the scope of these studies to animal models and,
ultimately, humans.
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